Home›Search›Anti-Obesity Drug Discovery and Development

Anti-Obesity Drug Discovery and Development

Bentham Science Publishers · United Arab Emirates · Est. 2018

ISSN2210-2698

SJR Q4✓ Scopus / SJR

/ 100

High Risk

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

✓ Scopus Q4+5

Total5

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Scorei

0.133

H-Indexi

Total Worksi

Total Citationsi

2yr Mean Citednessi

0.00

Open Impact Factor alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the discovery and development of anti-obesity drugs. It covers the global prevalence and health consequences of obesity, including its association with metabolic disorders, cardiovascular diseases, diabetes, and cancer. The journal also explores various therapeutic approaches, such as pharmacotherapies, natural products, and the role of specific biological targets like microRNAs, AMPK, and mitochondria in obesity treatment.

AI-summarised from recent articles · verify on the publisher page

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Bottom 25%

General Information

Country / RegionUnited Arab Emirates

Primary Language—

1st Year Published2018

Annual Volume~ 7 articles / year

StatusActive (last: 2021)

Total Publications20

Publisher OrgBentham Science Publishers

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2210-2698

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2018

2020

2021

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ4

Pharmaceutical ScienceQ4

Pharmacology (medical)Q4

Subject Classification

Scopus Categories

Pharmacology (medical)Drug DiscoveryPharmaceutical Science

Frequently asked questions about Anti-Obesity Drug Discovery and Development

Is Anti-Obesity Drug Discovery and Development a predatory journal?

No major predatory indicators were found for Anti-Obesity Drug Discovery and Development. It is indexed in Scopus and has a PubScope Trust Score of 5/100. Always confirm fit and policies before submitting.

What is the impact factor of Anti-Obesity Drug Discovery and Development?

Anti-Obesity Drug Discovery and Development is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.133.

Is Anti-Obesity Drug Discovery and Development indexed in Scopus and Web of Science?

Anti-Obesity Drug Discovery and Development is indexed in Scopus.